Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giles Best

Showing results (21-30 of 63) with videos related to

Pageof 7
Sort By:
Forensic Science International|January 17, 2026
A matter of age: Investigation of the ability to classify epithelial cells of different anatomical origin in aged samples using imaging flow cytometryDuncan Taylor, Abigail Skeffington, Ishana Somers, et al.
Leukemia & Lymphoma|December 14, 2011
The Hsp90 inhibitor SNX-7081 synergizes with and restores sensitivity to fludarabine in chronic lymphocytic leukemia cells with lesions in the TP53 pathway: a potential treatment strategy for fludarabine refractory diseaseO Giles Best, Yiping Che, Nisha Singh, et al.
British Journal of Haematology|July 7, 2018
The dual inhibitor of the phosphoinositol-3 and PIM kinases, IBL-202, is effective against chronic lymphocytic leukaemia cells under conditions that mimic the hypoxic tumour microenvironmentKyle Crassini, Yandong Shen, Michael O'Dwyer, et al.
The Biochemical Journal|July 20, 2005
A novel physical and functional association between nucleoside diphosphate kinase A and AMP-activated protein kinase alpha1 in liver and lungRussell M Crawford, Kate J Treharne, O Giles Best, et al.
Proteomics. Clinical Applications|May 30, 2012
Fludarabine nucleoside induces accumulations of p53, p63 and p73 in the nuclei of human B-lymphoid cell lines, with cytosolic and mitochondrial increases in p53Juhura G Almazi, Swetlana Mactier, O Giles Best, et al.
Journal of Extracellular Vesicles|April 19, 2016
Extensive surface protein profiles of extracellular vesicles from cancer cells may provide diagnostic signatures from blood samplesLarissa Belov, Kieran J Matic, Susannah Hallal, et al.
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|August 21, 2013
Profiles of surface mosaics on chronic lymphocytic leukemias distinguish stable and progressive subtypesPauline Y Huang, Philippa Kohnke, Larissa Belov, et al.
Frontiers in Microbiology|February 28, 2024
Benzalkonium chloride disinfectant residues stimulate biofilm formation and increase survival of <i>Vibrio</i> bacterial pathogensJulia Mougin, Graziella Midelet, Sophie Leterme, et al.
Nucleosides, Nucleotides & Nucleic Acids|June 19, 2014
Mechanisms of action of fludarabine nucleoside against human Raji lymphoma cellsRichard I Christopherson, Swetlana Mactier, Juhura G Almazi, et al.
British Journal of Haematology|May 17, 2018
MEK1/2 inhibition by binimetinib is effective as a single agent and potentiates the actions of Venetoclax and ABT-737 under conditions that mimic the chronic lymphocytic leukaemia (CLL) tumour microenvironmentKyle Crassini, Yandong Shen, William S Stevenson, et al.
Pageof 7

Showing results (21-30 of 63) with videos related to

Sort By:
Pageof 7
Forensic Science International|January 17, 2026
A matter of age: Investigation of the ability to classify epithelial cells of different anatomical origin in aged samples using imaging flow cytometryDuncan Taylor, Abigail Skeffington, Ishana Somers, et al.
Leukemia & Lymphoma|December 14, 2011
The Hsp90 inhibitor SNX-7081 synergizes with and restores sensitivity to fludarabine in chronic lymphocytic leukemia cells with lesions in the TP53 pathway: a potential treatment strategy for fludarabine refractory diseaseO Giles Best, Yiping Che, Nisha Singh, et al.
British Journal of Haematology|July 7, 2018
The dual inhibitor of the phosphoinositol-3 and PIM kinases, IBL-202, is effective against chronic lymphocytic leukaemia cells under conditions that mimic the hypoxic tumour microenvironmentKyle Crassini, Yandong Shen, Michael O'Dwyer, et al.
The Biochemical Journal|July 20, 2005
A novel physical and functional association between nucleoside diphosphate kinase A and AMP-activated protein kinase alpha1 in liver and lungRussell M Crawford, Kate J Treharne, O Giles Best, et al.
Proteomics. Clinical Applications|May 30, 2012
Fludarabine nucleoside induces accumulations of p53, p63 and p73 in the nuclei of human B-lymphoid cell lines, with cytosolic and mitochondrial increases in p53Juhura G Almazi, Swetlana Mactier, O Giles Best, et al.
Journal of Extracellular Vesicles|April 19, 2016
Extensive surface protein profiles of extracellular vesicles from cancer cells may provide diagnostic signatures from blood samplesLarissa Belov, Kieran J Matic, Susannah Hallal, et al.
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|August 21, 2013
Profiles of surface mosaics on chronic lymphocytic leukemias distinguish stable and progressive subtypesPauline Y Huang, Philippa Kohnke, Larissa Belov, et al.
Frontiers in Microbiology|February 28, 2024
Benzalkonium chloride disinfectant residues stimulate biofilm formation and increase survival of <i>Vibrio</i> bacterial pathogensJulia Mougin, Graziella Midelet, Sophie Leterme, et al.
Nucleosides, Nucleotides & Nucleic Acids|June 19, 2014
Mechanisms of action of fludarabine nucleoside against human Raji lymphoma cellsRichard I Christopherson, Swetlana Mactier, Juhura G Almazi, et al.
British Journal of Haematology|May 17, 2018
MEK1/2 inhibition by binimetinib is effective as a single agent and potentiates the actions of Venetoclax and ABT-737 under conditions that mimic the chronic lymphocytic leukaemia (CLL) tumour microenvironmentKyle Crassini, Yandong Shen, William S Stevenson, et al.
Pageof 7